

From Biotech to Asset Management with Sunaina Sinha
56 snips Jan 2, 2025
Sunaina Sinha, Global Head of Private Capital Advisory at Raymond James, shares her journey from biotech to asset management. She discusses the increasing significance of AI across industries and highlights the distinct investment landscapes of the US and UK. With insights from her experiences as a third culture kid, she emphasizes the importance of cultural fit in career transitions and building long-term relationships in private equity. Sunaina also reflects on the growing interest in private equity among high-net-worth individuals and the complexities of capital raising.
AI Snips
Chapters
Books
Transcript
Episode notes
Biotech to Asset Management
- Sunaina Sinha initially planned to work in biotech, earning a master's in chemical engineering from Stanford.
- After working with two biotech companies, she realized the industry wasn't a long-term fit, leading her to pursue an MBA at Harvard and transition into asset management.
Global Upbringing and Stanford
- Sunaina Sinha's global upbringing and diverse experiences shaped her entrepreneurial drive.
- Stanford's focus on entrepreneurship and technology aligned with her desire to build and scale businesses.
Hedge Fund Experience
- Sunaina Sinha's experience in capital raising at Bridgewater and Brevan Howard provided valuable insights into investor behavior and market dynamics.
- Her macro hedge fund experience taught her how different market factors impact various investor types, knowledge she now applies to her private equity work.